BlackRock Inc. - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 215 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$189,348,826
-31.6%
22,676,506
+8.9%
0.01%
-37.5%
Q2 2023$276,944,609
+18.4%
20,822,903
+3.1%
0.01%
+14.3%
Q1 2023$233,938,002
+54.3%
20,201,900
+9.0%
0.01%
+40.0%
Q4 2022$151,619,410
+45.8%
18,535,380
+3.5%
0.01%
+25.0%
Q3 2022$103,959,000
+28.0%
17,908,556
-2.6%
0.00%
+33.3%
Q2 2022$81,246,000
-46.2%
18,381,661
+10.7%
0.00%
-25.0%
Q1 2022$151,146,000
-55.4%
16,609,353
+0.2%
0.00%
-55.6%
Q4 2021$339,007,000
-17.8%
16,569,244
+2.7%
0.01%
-25.0%
Q3 2021$412,197,000
-27.2%
16,132,971
-0.3%
0.01%
-25.0%
Q2 2021$566,145,000
+3.1%
16,189,432
-1.8%
0.02%0.0%
Q1 2021$549,386,000
+40.1%
16,493,115
+9.1%
0.02%
+23.1%
Q4 2020$392,094,000
+175.5%
15,115,490
+4.8%
0.01%
+160.0%
Q3 2020$142,316,000
+209.1%
14,419,191
+8.1%
0.01%
+150.0%
Q2 2020$46,036,000
+17.2%
13,343,578
+4.0%
0.00%0.0%
Q1 2020$39,275,000
-36.5%
12,834,826
+6.7%
0.00%0.0%
Q4 2019$61,851,000
+1.2%
12,033,320
+1.6%
0.00%
-33.3%
Q3 2019$61,111,000
-13.7%
11,843,418
+1.2%
0.00%0.0%
Q2 2019$70,776,000
-12.1%
11,698,356
+5.0%
0.00%
-25.0%
Q1 2019$80,531,000
-3.3%
11,138,603
-1.0%
0.00%0.0%
Q4 2018$83,298,000
+54.4%
11,256,330
+12.9%
0.00%
+100.0%
Q3 2018$53,953,000
+57.6%
9,972,840
+3.4%
0.00%0.0%
Q2 2018$34,230,000
+89.9%
9,642,174
+9.7%
0.00%
+100.0%
Q1 2018$18,023,000
-16.3%
8,792,739
+7.8%
0.00%0.0%
Q4 2017$21,531,000
-56.3%
8,155,624
-13.0%
0.00%
-50.0%
Q3 2017$49,219,000
+80.5%
9,375,016
+22.4%
0.00%
+100.0%
Q2 2017$27,268,000
-34.1%
7,659,492
-4.3%
0.00%
-50.0%
Q1 2017$41,387,000
+7384.1%
8,005,472
+5397.5%
0.00%
+100.0%
Q4 2016$553,000
-57.9%
145,619
-0.5%
0.00%
-50.0%
Q3 2016$1,312,000
+38.7%
146,412
+8.9%
0.00%
+100.0%
Q2 2016$946,000
-31.3%
134,502
-17.0%
0.00%
-50.0%
Q1 2016$1,378,000
-27.8%
162,042
+11.5%
0.00%
-33.3%
Q4 2015$1,909,000
+231.4%
145,349
-7.6%
0.00%
+200.0%
Q3 2015$576,000
+18.5%
157,387
+86.4%
0.00%0.0%
Q2 2015$486,000
+5975.0%
84,421
+5841.0%
0.00%
Q1 2015$8,000
-27.3%
1,4210.0%0.00%
Q4 2014$11,000
+57.1%
1,4210.0%0.00%
Q3 2014$7,000
-22.2%
1,4210.0%0.00%
Q2 2014$9,000
+12.5%
1,4210.0%0.00%
Q1 2014$8,000
+33.3%
1,421
+26.0%
0.00%
Q4 2013$6,0000.0%1,1280.0%0.00%
Q3 2013$6,0001,1280.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q4 2020
NameSharesValueWeighting ↓
Madrone Advisors, LLC 16,415,933$137,073,04129.47%
ORACLE INVESTMENT MANAGEMENT INC 1,638,395$13,680,5984.20%
Decheng Capital Management III (Cayman), LLC 1,463,872$12,223,3314.08%
VK Services, LLC 2,632,784$21,983,7462.93%
Iron Triangle Partners LP 1,800,000$15,030,0002.20%
BOURNE LENT ASSET MANAGEMENT INC 574,350$4,795,8222.11%
Deep Track Capital, LP 6,000,000$50,100,0001.93%
Jackson Square Partners, LLC 6,933,865$57,897,7731.93%
ARK Investment Management 29,822,440$249,017,3701.90%
Nikko Asset Management Americas, Inc. 13,447,666$112,153,5341.34%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders